Dietary unsaturated fat increases HDL metabolic pathways involving apoE favorable to reverse cholesterol transport.
Adult
Aged
Apolipoproteins E
/ metabolism
Coronary Disease
/ blood
Cross-Over Studies
Diet, Carbohydrate Loading
/ methods
Diet, High-Fat
/ methods
Dietary Fats, Unsaturated
/ administration & dosage
Female
Humans
Lipoproteins, HDL
/ metabolism
Male
Metabolic Networks and Pathways
Middle Aged
Obesity
/ blood
Treatment Outcome
Lipoproteins
Metabolism
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
04 04 2019
04 04 2019
Historique:
received:
30
08
2018
accepted:
14
02
2019
entrez:
5
4
2019
pubmed:
5
4
2019
medline:
1
7
2020
Statut:
epublish
Résumé
HDL that contains apolipoprotein E (apoE) is a subspecies especially active in steps in reverse cholesterol transport, a process that brings cholesterol from peripheral cells to the liver. Here, we studied the effect of dietary unsaturated fat compared with carbohydrate on the metabolism of HDL containing apoE. We enrolled 9 adults who were overweight or obese and had below-average HDL-cholesterol in a crossover study of a high-fat diet, primarily unsaturated, and a low-fat, high-carbohydrate diet. A metabolic tracer study was performed after each diet period. Dietary fat increased the secretion, metabolism, and clearance of HDL subspecies containing apoE. Dietary fat increased the rate of clearance of large cholesterol-rich HDL containing apoE and increased their conversion to small HDL containing apoE, indicating selective cholesterol ester delivery to the liver. The high-unsaturated-fat diet did not affect the metabolism of HDL lacking apoE. HDL containing apoE is a diet-responsive metabolic pathway that renders HDL more biologically active in reverse cholesterol transport. This may be a mechanism by which unsaturated fat protects against coronary heart disease. Protein-based HDL subspecies such as HDL containing apoE may be used to identify additional atheroprotective treatment targets not evident in the total HDL-cholesterol measurement. ClinicalTrials.gov NCT01399632. NIH and the National Center for Advancing Translational Science.
Sections du résumé
BACKGROUND
HDL that contains apolipoprotein E (apoE) is a subspecies especially active in steps in reverse cholesterol transport, a process that brings cholesterol from peripheral cells to the liver. Here, we studied the effect of dietary unsaturated fat compared with carbohydrate on the metabolism of HDL containing apoE.
METHODS
We enrolled 9 adults who were overweight or obese and had below-average HDL-cholesterol in a crossover study of a high-fat diet, primarily unsaturated, and a low-fat, high-carbohydrate diet. A metabolic tracer study was performed after each diet period.
RESULTS
Dietary fat increased the secretion, metabolism, and clearance of HDL subspecies containing apoE. Dietary fat increased the rate of clearance of large cholesterol-rich HDL containing apoE and increased their conversion to small HDL containing apoE, indicating selective cholesterol ester delivery to the liver. The high-unsaturated-fat diet did not affect the metabolism of HDL lacking apoE.
CONCLUSION
HDL containing apoE is a diet-responsive metabolic pathway that renders HDL more biologically active in reverse cholesterol transport. This may be a mechanism by which unsaturated fat protects against coronary heart disease. Protein-based HDL subspecies such as HDL containing apoE may be used to identify additional atheroprotective treatment targets not evident in the total HDL-cholesterol measurement.
TRIAL REGISTRATION
ClinicalTrials.gov NCT01399632.
FUNDING
NIH and the National Center for Advancing Translational Science.
Identifiants
pubmed: 30944249
pii: 124620
doi: 10.1172/jci.insight.124620
pmc: PMC6483656
doi:
pii:
Substances chimiques
Apolipoproteins E
0
Dietary Fats, Unsaturated
0
Lipoproteins, HDL
0
apolipoprotein E-rich HDL
0
Banques de données
ClinicalTrials.gov
['NCT01399632']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL095964
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007575
Pays : United States
Références
Biochim Biophys Acta. 1979 Oct 26;575(1):81-91
pubmed: 228738
Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):918-24
pubmed: 10195918
Biochem J. 2007 Apr 15;403(2):359-67
pubmed: 17206937
J Lipid Res. 2007 May;48(5):1190-203
pubmed: 17314277
J Clin Invest. 2006 May;116(5):1226-9
pubmed: 16670767
Biochemistry. 1980 Sep 2;19(18):4359-65
pubmed: 7417411
Metabolism. 1998 Apr;47(4):484-92
pubmed: 9550550
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
J Biol Chem. 1981 Jun 10;256(11):5646-55
pubmed: 6263887
J Lipid Res. 2004 Dec;45(12):2331-8
pubmed: 15342678
J Lipid Res. 2001 Oct;42(10):1586-93
pubmed: 11590214
Circulation. 2017 Jul 18;136(3):e1-e23
pubmed: 28620111
Circulation. 2003 Aug 12;108(6):661-3
pubmed: 12900335
J Lipid Res. 1999 Oct;40(10):1782-92
pubmed: 10508197
J Biol Chem. 2005 Feb 18;280(7):5414-22
pubmed: 15583000
J Clin Invest. 1982 Dec;70(6):1157-69
pubmed: 6294137
Circulation. 2006 May 30;113(21):2548-55
pubmed: 16735689
J Clin Invest. 1990 Jan;85(1):144-51
pubmed: 2104877
J Lipid Res. 2014 Oct;55(10):2167-77
pubmed: 24966274
Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):487-499
pubmed: 29371248
J Biol Chem. 1985 Oct 5;260(22):11934-43
pubmed: 2995353
Biochim Biophys Acta. 1983 May 24;737(2):197-222
pubmed: 6303423
N Engl J Med. 2011 Jan 13;364(2):127-35
pubmed: 21226578
J Lipid Res. 1994 Oct;35(10):1809-19
pubmed: 7852858
Nat Struct Mol Biol. 2011 Apr;18(4):416-22
pubmed: 21399642
J Lipid Res. 2009 May;50(5):894-907
pubmed: 19144994
J Lipid Res. 2008 Jan;49(1):115-26
pubmed: 17921435
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):239-45
pubmed: 19910636
JCI Insight. 2018 Feb 22;3(4):
pubmed: 29467335
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):156-65
pubmed: 26543096
Am J Clin Nutr. 2003 May;77(5):1146-55
pubmed: 12716665
J Lipid Res. 2017 Apr;58(4):752-762
pubmed: 28167703
Nature. 1989 Sep 14;341(6238):162-4
pubmed: 2779654
J Clin Invest. 1972 Aug;51(8):2103-14
pubmed: 4341014
Curr Opin Lipidol. 2010 Jun;21(3):218-28
pubmed: 20463470
JAMA. 2005 Nov 16;294(19):2455-64
pubmed: 16287956
J Clin Invest. 2013 Jun;123(6):2742-51
pubmed: 23676495
Circ Res. 2005 Oct 14;97(8):763-71
pubmed: 16151025
Arteriosclerosis. 1984 Sep-Oct;4(5):452-61
pubmed: 6089725